Troy Edward Wilson - 12 Dec 2023 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Director
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Issuer symbol
RNA
Transactions as of
12 Dec 2023
Net transactions value
$0
Form type
4
Filing time
14 Dec 2023, 06:50:54 UTC
Previous filing
11 Dec 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNA Common Stock Other $0 -300,000 -53% $0.000000 263,711 12 Dec 2023 By family trust F1
transaction RNA Common Stock Other $0 +300,000 $0.000000 300,000 12 Dec 2023 By trust FBO Children 1 and 2 F1
transaction RNA Common Stock Other $0 -250,000 -95% $0.000000 13,711 12 Dec 2023 By family trust F1
transaction RNA Common Stock Other $0 +250,000 +500% $0.000000 300,000 12 Dec 2023 By trust FBO Children 3 and 4 F1
holding RNA Common Stock 35,553 12 Dec 2023 By trust FBO Child 1
holding RNA Common Stock 35,553 12 Dec 2023 By trust FBO Child 2
holding RNA Common Stock 11,851 12 Dec 2023 By trust FBO Child 3
holding RNA Common Stock 11,851 12 Dec 2023 By trust FBO Child 4
holding RNA Common Stock 62,733 12 Dec 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family.